CDKN2D | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	21 studies	27% ± 12%	Explore
plasmacytoid dendritic cell	16 studies	39% ± 13%	Explore
B cell	15 studies	25% ± 9%	Explore
non-classical monocyte	13 studies	45% ± 21%	Explore
CD16-positive, CD56-dim natural killer cell, human	12 studies	31% ± 9%	Explore
classical monocyte	12 studies	33% ± 19%	Explore
platelet	10 studies	42% ± 20%	Explore
CD8-positive, alpha-beta T cell	10 studies	23% ± 11%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	33% ± 15%	Explore
gamma-delta T cell	9 studies	23% ± 9%	Explore
T cell	7 studies	22% ± 8%	Explore
endothelial cell	7 studies	18% ± 2%	Explore
CD4-positive, alpha-beta T cell	7 studies	29% ± 11%	Explore
memory B cell	7 studies	22% ± 5%	Explore
megakaryocyte	6 studies	57% ± 22%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	22% ± 5%	Explore
monocyte	5 studies	29% ± 5%	Explore
conventional dendritic cell	5 studies	35% ± 21%	Explore
dendritic cell	5 studies	36% ± 27%	Explore
mature NK T cell	5 studies	28% ± 12%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	22% ± 7%	Explore
neuron	5 studies	32% ± 17%	Explore
precursor B cell	5 studies	41% ± 7%	Explore
erythrocyte	5 studies	26% ± 7%	Explore
neutrophil	4 studies	22% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	34% ± 11%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	23% ± 8%	Explore
retinal ganglion cell	4 studies	65% ± 24%	Explore
myeloid cell	4 studies	25% ± 9%	Explore
pro-B cell	4 studies	26% ± 6%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	27% ± 17%	Explore
innate lymphoid cell	4 studies	23% ± 5%	Explore
glutamatergic neuron	4 studies	35% ± 14%	Explore
CD4-positive, alpha-beta memory T cell	4 studies	21% ± 5%	Explore
leukocyte	3 studies	20% ± 3%	Explore
epithelial cell	3 studies	17% ± 1%	Explore
immature B cell	3 studies	36% ± 12%	Explore
ciliated cell	3 studies	22% ± 2%	Explore
naive B cell	3 studies	22% ± 4%	Explore
GABAergic neuron	3 studies	24% ± 7%	Explore
mucosal invariant T cell	3 studies	18% ± 1%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	13 studies	30% ± 16%	Explore
lung	3 studies	21% ± 3%	Explore
bone marrow	3 studies	20% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
brain	99%	3696.68	2628 / 2642	100%	40.75	705 / 705
lung	99%	1547.68	571 / 578	98%	23.04	1137 / 1155
esophagus	84%	609.64	1212 / 1445	100%	23.95	183 / 183
skin	84%	695.33	1523 / 1809	99%	29.31	469 / 472
intestine	83%	638.00	800 / 966	99%	20.21	522 / 527
bladder	76%	516.05	16 / 21	99%	28.44	497 / 504
breast	66%	396.15	301 / 459	98%	26.47	1092 / 1118
kidney	65%	413.12	58 / 89	96%	12.83	868 / 901
adrenal gland	59%	351.71	152 / 258	100%	63.08	229 / 230
prostate	50%	289.09	122 / 245	97%	11.11	486 / 502
uterus	46%	277.53	78 / 170	100%	43.49	459 / 459
stomach	38%	269.04	136 / 359	99%	20.56	283 / 286
ovary	26%	151.43	47 / 180	97%	26.19	418 / 430
thymus	26%	138.70	167 / 653	97%	33.53	586 / 605
pancreas	2%	12.67	8 / 328	99%	30.30	176 / 178
lymph node	0%	0	0 / 0	100%	44.53	29 / 29
spleen	100%	2187.89	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	48.84	45 / 45
ureter	0%	0	0 / 0	100%	40.62	1 / 1
peripheral blood	98%	8618.34	914 / 929	0%	0	0 / 0
blood vessel	95%	891.01	1264 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	84%	8.27	67 / 80
adipose	83%	592.30	1003 / 1204	0%	0	0 / 0
liver	7%	36.77	16 / 226	69%	7.75	280 / 406
muscle	67%	467.82	538 / 803	0%	0	0 / 0
heart	55%	348.99	472 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0043154	Biological process	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO_0007605	Biological process	sensory perception of sound
GO_0008285	Biological process	negative regulation of cell population proliferation
GO_1902807	Biological process	negative regulation of cell cycle G1/S phase transition
GO_0000079	Biological process	regulation of cyclin-dependent protein serine/threonine kinase activity
GO_2000045	Biological process	regulation of G1/S transition of mitotic cell cycle
GO_0009411	Biological process	response to UV
GO_0042326	Biological process	negative regulation of phosphorylation
GO_0048102	Biological process	autophagic cell death
GO_1902230	Biological process	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage
GO_0000731	Biological process	DNA synthesis involved in DNA repair
GO_0032526	Biological process	response to retinoic acid
GO_0033280	Biological process	response to vitamin D
GO_0030308	Biological process	negative regulation of cell growth
GO_0005654	Cellular component	nucleoplasm
GO_0097129	Cellular component	cyclin D2-CDK4 complex
GO_0005829	Cellular component	cytosol
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0019901	Molecular function	protein kinase binding
GO_0004861	Molecular function	cyclin-dependent protein serine/threonine kinase inhibitor activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	CDKN2D
Protein name	Cyclin-dependent kinase 4 inhibitor D (p19-INK4d)
Synonyms
Description	FUNCTION: Interacts strongly with CDK4 and CDK6 and inhibits them. .
Accessions	P55273 ENST00000393599.3 ENST00000335766.2

CDKN2D report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review